Page 4 - Best Bladder cancer doctors: TOP 117 doctors

Dr. Son Dong Wan, MD, PhD, is the Chief of Urology at Naeun Hospital. He specializes in urologic oncology, urinary incontinence, sexual dysfunction, and laser prostate surgery. He performs robotic and laparoscopic surgery for cancers of the prostate, bladder, ureter, and kidney. He also treats ureteropelvic junction (UPJ) obstruction.

He earned his PhD from Pusan National University. He completed his internship and residency at Pusan National University Hospital. He is a former Chief at Wallace Memorial Baptist Hospital. He served as a Professor at the Catholic University College of Medicine. He was a Clinical Fellow at Seoul National University Bundang Hospital. He was a Visiting Professor at the University of California, San Diego (UCSD). He completed training in urinary incontinence surgery at the University of Liège.

Awards include the Excellent Paper Award (2007) and the Academic Achievement Award (2014) from the Korean Continence Society. He also received the Best Poster Award from the European Association of Urology (2013).

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. David Kuczer is a specialist in radio-oncology with many years of experience in cancer diagnosis and treatment. He offers fast access to precise radiotherapy based on current scientific standards.

He is a member of the Cancer Center at the Vienna Private Clinic. He presents each patient to the in-house tumor board. This allows an interdisciplinary discussion by an internationally renowned team and helps select the best treatment.

All radiation treatments are provided in close cooperation with Amethyst Radiotherapy at the Vienna Private Clinic.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Urologist, Surgeon

Head of the Samsung Department of Urology – Dr. Choi Han Yong specializes in bladder cancer treatments at Samsung Medical Center.

• Oncosurgeon with a focus on urological cancers
• Leads a top-tier urology department
• Experienced in advanced bladder cancer procedures

Michael Van Kampen is a dedicated radiotherapy specialist with extensive experience in treating urological cancers like bladder cancer.

• Years of focused clinical practice in radiation oncology
• Applies targeted radiotherapy techniques to treat cancerous cells
• Works at the specialized Nordwest Clinic in Frankfurt
• Part of a multidisciplinary team for comprehensive cancer care

Prof. Dr. Eduard Becht brings of urology experience and an honorary doctorate to his work at Nordwest Clinic. His expertise spans from minimally invasive treatments to complex organ-preserving surgeries.

• Specializes in uro-oncology and reconstructive urology
• Awarded honorary doctorate from Kapodiastrias University of Athens
• Chairman of Interdisciplinary Urooncology Frankfurt association
• Published over 100 scientific papers on urological conditions
• Lecturer at Goethe University in Frankfurt since 1994

Dr. Yurdakul specializes in uro-oncology with advanced training from Cleveland Clinic Ohio and University of Pittsburgh, focusing on bladder cancer treatments.

• 76 years of experience of experience in urology and uro-oncology
• Published 16 international and 58 national scientific articles
• Trained in microvascular surgery at Mercy University
• Speaker and session chairman at national urology meetings

Dr. Amiel is the Head of the Urology Department at Rambam Medical Center, focusing on cancer surgery. His role highlights deep expertise in complex urological cases.

• Specializes as an oncosurgeon for urinary system cancers
• Provides care at a major university hospital in Israel

Dr. Yutkin has over 30 years of experience of experience in diagnosis and treatment at Hadassah Medical Center.

• Graduated from the Faculty of Medicine of the Hebrew University of Jerusalem
• Specializes in temporomandibular joint disorders
• Fluent in English, Hebrew, and Russian

Professor Gofrit is certified to perform robotic surgery for urological cancers. He leads the Urology Department at Hadassah Medical Center.

• Completed specialized urologic oncology training in Chicago, USA
• Researches and treats cancers of the bladder and kidney specifically
• Teaches urological surgery at the Hebrew University
• Holds national and international awards for his work in urology
• Specializes in endoscopic and robot-assisted da Vinci surgery

Prof. Jablonski-Perec trained at Sloan-Kettering Cancer Center – one of the world's top oncology institutions – and leads the Institute of Oncology at Hadassah Medical Center.

• Head of Breast Cancer Treatment Center since 1998
• Professor of Oncology at Hebrew University
• Member of several international cancer communities
• Awarded scholarship from Hadassah Medical School

Radiotherapist specializing in bladder cancer treatment at Assuta Medical Center.

• Specialized in radiation therapy
• Has experience treating various oncological conditions
• Practices evidence-based treatment approaches

Specialist in oncourology – focuses exclusively on bladder cancer at Assuta Medical Center.

• Urologist with deep expertise in bladder cancer treatment
• Works at Assuta Medical Center – a leading oncology facility
• Dedicated to oncourology, ensuring specialized care

Assoc. Prof. Serap Kaya brings specialized oncology expertise from academic hospitals to Emsey Hospital.

• Specialized in Medical Oncology at Kocaeli University
• Practiced at Kartal Dr. Lütfi Kırdar Training and Research Hospital
• Current faculty member at Emsey Hospital
• Experienced in both adult and pediatric oncology

Dr. Osama Abdel Mohimen Mohamed is Head of the Hematology Unit at Shefaa Al Orman Oncology Hospitals. He is also a consultant in medical oncology and hematology at Shefa El Orman Hospital (NGO), Luxor (2019–present).

He diagnoses and treats acute and chronic leukemia, lymphoma, myeloma, myelodysplastic syndromes, and myeloproliferative neoplasms. He also manages complications of solid tumors.

Background: He served at the National Cancer Institute, Cairo University, as a medical oncology resident, then demonstrator and assistant lecturer (2008–2022). Earlier, he was a house officer (2006–2007). He also held specialist roles at Al Salam International, Al Molalmen, and BAHEYA Oncology Center (NGO).

Memberships: ESMO (2008–present). American Society of Bone Marrow Transplantation (2009). ASH (2010).